Anemia aplásica en la población pediátrica de Costa Rica: experiencia de 10 años
DOI:
https://doi.org/10.51481/amc.v62i3.1075Keywords:
pediatrics, aplastic anemia, acquired aplastic anemia, bone marrow transplant, antithymocite globulinAbstract
Objective: Aplastic anemia is a rare and life-threatening disease without diagnosis and early reatment. The objective of this study was to describe the epidemiological characters of patients with aplastic anemia and 0-13 years old in Costa Rica, to treat in the Hospital Nacional de Niños Dr. Carlos Sáenz Herrera, Caja Costarricense de Seguro Social; only there offers Pediatric Hematology service.
Methods: We performed an observational retrospective study, there including the patients diagnosed with both acquired aplastic anemia and inherited bone marrow failure syndromes from January 2006 to June 2016, regardless of sex or ethnicity. We evaluated the treatment received, the response to each treatment, and mortality associated with the disease.
Results: An overall of 27 patients were included, 23 diagnosed with acquired aplastic anemia and, 4 with bone marrow failure syndrome. The mean age of diagnosis was 81.7 months, with a male to female ratio of 1.1:1. Of the 23 patients diagnosed with acquired aplastic anemia, 10 received immunosuppressive therapy with antithymocite globulin, with a response to horse globulin as a first line treatment in 2/5 patients, and 1 as a second line treatment. Patients with rabbit globulin showed to response in 1/5 cases when used as a first line treatment, and a response as a second line treatment after a no response treatment with horse globulin in 2/3 patients. Three patients treated with a matched related donor bone marrow transplant and showed complete response, without complications including graft versus host disease by the end of the study period. There was no statistical difference regarding sex, age of diagnosis, blood cell counts, frequency of blood product transfusions, degree of severity associated or, mortality.
Conclusions: Our results confirm the low incidence of aplastic anemia, it's a little study population and has limited results of relevant characteristics and can t compare with international studies.
Downloads
References
Miano M, DuFour C. The diagnosis and treatment of aplastic anemia: a review. Int J Hematol. 2015; 101:527-535.
Young NS. Aplastic Anemia. N Eng J Med. 2018; 379: 1643-56.
DeZern A, Brosky R. Clinical management of aplastic anemia. Expert Rev. Hematol. 2011; 4: 221-230.
Rauff B, Idrees M, Riaz Shah SH, Butt S, Butt AM, Ali L et al. Hepatitis Associated Aplastic Anemia: a review. Virology Journal. 2011; 8: 87.
Chul D, Gyun Chung N, JIng Kang H, Hoe Koo H, Kook H, Ki Kim S et al. Epidemiology and Clinical Long-term Outcome of Childhood Aplastic Anemia in Korea for 15 Years: Retrospective Study of the Korean Society of Pediatric Hematology Oncology (KSPHO). J Pediatr Hematol Oncol. 2011; 33: 172-178.
Hartung H, Olson T, Bessler M. Acquired Aplastic Anemia in Children. Pediatr Clin N Am. 2013; 60: 1311-1336.
Camitta BM, Rappeport JM, Parkman R, Nathan DG. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood 1975; 45: 355-63.
Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT et al. Bone Marrow Transplantation versus immunossuppresion for the treatment of severe aplastic anemia: a report of the EBMT SAA working party. Br J Haematol 1988; 70: 177-82.
Korthof ET, Békássy AN; Hussein AA. Management of acquired aplastic anemia. Bone Marrow Transplantation. 2013; 48: 191-195.
Hayakawa J, Kanda J, Akahoshi Y, Harada N, Kameda K, Ugai T et al. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. Int J Hematol. 2017; 105: 578-586.
Kook H, Chung N, Jin Kang, H; Joom In, H. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology. Int J Hematol. 2016; 103:380-386.
Yoshida N, Kojima S. Updated Guidelines for the treatment of acquired aplastic anemia in children. Current Oncology Reports. 2018; 20: 67.
Williams D, Bennett C, Bertuch A, Bessler M, Coates T, Corey S et al. Diagnosis and treatment of pediatriac acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer. 2014; 61: 869-874.
Choi YB, Yi ES, Lee JW, Sung KW, Koo HH, Yoo KH. Immunosuppressive therapy versus alternative hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor. Bone Marrow Transplantation. 2017,52: 47-52.
Bacigalupo A, Bruno B, Saracco P, DiBona E, Locasciulli A, Locatelli F, et al. ntilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. BLOOD. 2000; 95: 1931-1934.
Hernández C. Anemia aplásica en los años 1996 - 2005 Hospital Nacional de Niños Carlos Sáenz Herrera: primer reporte a nivel centroamericano. Tesis UCR. CEC-HNN-004-2006.
Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe K et al. First line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy. Haemotologica. 2014; 99: 1784-1791.
Barone A, Lucarelli A, Onofrillo D, Verzegnassi F, Bonanomi S, Cesaro S et al. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP). Blood cells, molecules and diseases. 2015; 55: 40—47.
Afable M, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H et al. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica. 2011; 96: 1269-1275.
Vallejo C, Montesinos P, Polo M, Cuevas B, Morado M, Rosell A et al. Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatmenof acquired aplastic anemia: a retrospective analysis. Ann Hematol. 2015; 94:947-954.
Yang N, Chen J, Zhang H, Dai Z, Yao H, Ma X et al. Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis. Ann Hematol. 2017; 96:2031-2043.
Jain R, Trehan A, Bansal D, Varma N. Aplastic anemia in children: How good is immunosuppressive therapy? Pediatric Hematology Oncology. 2019; 36: 6:211-221
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
